Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 05-2017 | 02-2017 | |
| Sales | 29 | 13 |
| Cost of Goods | 9 | 15 |
| Gross Profit | 20 | -2 |
| Operating Expenses | 226 | 340 |
| Operating Income | -197 | -328 |
| Interest Expense | 2 | 2 |
| Other Income | -145 | -135 |
| Pre-tax Income | -344 | -465 |
| Net Income Continuous | -344 | -465 |
| Net Income | $-344 | $-465 |
| EPS Basic Total Ops | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.17 | -0.25 |
| EPS Diluted Total Ops | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.17 | -0.25 |
| EBITDA(a) | $-195 | $-326 |